Korro Bio, Inc.

KRRONasdaq· Pharmaceutical Preparations

Price History

Revenue

$6.4M

▲ 181.5% YoY

Net Income

-$117.3M

▼ 40.3% YoY

EPS

$-12.48

▼ 33.2% YoY

Cash

$21.8M

▼ 60.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.